Patients with atrial fibrillation treated with apixaban are less likely to discontinue study drug when compared with warfarin : insights from the ARISTOTLE trial

Xavier, D. (author)

St Johns Med Coll Hosp, Bangalore, Karnataka, India.

Hanna, M. (author)

Bristol Myers Squibb, Princeton, NJ USA.

Wallentin, Lars (author)

Uppsala universitet,Kardiologi

show more...

Alexander, J. (author)

Duke Clin Res Inst, Cardiol, Durham, NC USA.

Lopes, R. (author)

Duke Clin Res Inst, Cardiol, Durham, NC USA.

Merrill, P. (author)

Duke Clin Res Inst, Cardiol, Durham, NC USA.

Wojdyla, D. (author)

Duke Clin Res Inst, Cardiol, Durham, NC USA.

Bahit, C. (author)

INECO Neurociencias Orono, Rosario, Argentina.

Hohnloser, S. (author)

Goethe Univ Frankfurt, Frankfurt, Germany.

Granger, C. (author)

Duke Clin Res Inst, Cardiol, Durham, NC USA.

show less...

St Johns Med Coll Hosp, Bangalore, Karnataka, India Bristol Myers Squibb, Princeton, NJ USA. (creator_code:org_t)

2016

2016

English.

Related links:

https://urn.kb.se/re...

• Conference paper (peer-reviewed)